Narrow Dental Implants in Multiple Fixed Prosthesis

Fundación Eduardo Anitua1 site in 1 country48 target enrollmentAugust 1, 2019

ConditionsEdentulous Alveolar Ridge

Overview

Phase: N/A
Intervention: Not specified
Conditions: Edentulous Alveolar Ridge
Sponsor: Fundación Eduardo Anitua
Enrollment: 48
Locations: 1
Primary Endpoint: Survival after 5 years of follow-up
Status: Active, Not Recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study is to evaluate the survival of narrow dental implants (≤ 3,5 mm) in multiple fixed prostheses in comparison with standard diameter dental implants (≥ 3,75 mm) after 5 years of follow-up. The hypothesis of the study is that narrow dental implants under the evaluated conditions, have the same survival rate and clinical performance than the standard diameter implants.

Registry

clinicaltrials.gov

Start Date

August 1, 2019

End Date

January 31, 2026

Last Updated

last year

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Fundación Eduardo Anitua

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients of legal age (\>18 years) of both sexes.
•Clinical need of multiple fixed alveolar ridge rehabilitations.
•Clinical suitability to insert, at least, one narrow dental implant splinted to a standard diameter dental implant.
•Signature of the informed consent

Exclusion Criteria

•Presence of an active infection
•Being under active treatment with, or have received in the las 30 days treatment with radiotherapy, chemotherapy, immunosuppressors, systemic corticosteroids and/or anticoagulants.
•Presence of severe haematologic disorders.
•Chronic treatment with non steroidal anti-inflammatory drugs (NSAID) or other aniinflammatory drugs.
•Previous diagnosis of chronic hepatitis or liver cirrhosis.
•Presence of Diabetes mellitus with improper metabolic control (glycosylated haemoglobine higher that 9%).
•Patients subjected to dialysis.
•Presence of malignant tumours, haemangioma or angioma in the surgical area.
•History of ischaemic cardiopathy in the las year.
•Pregnancy or plan to getting pregnant during the study.